Torres J, Palmela C, Brito H, Bao X, Ruiqi H, Moura-Santos P, Pereira da Silva J, Oliveira A, Vieira C, Perez K, Itzkowitz S H, Colombel J F, Humbert L, Rainteau D, Cravo M, Rodrigues C M, Hu J
Surgical Department, Hospital Beatriz Ângelo, Loures, Portugal.
Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA.
United European Gastroenterol J. 2018 Feb;6(1):112-122. doi: 10.1177/2050640617708953. Epub 2017 May 5.
Patients with primary sclerosing cholangitis associated with inflammatory bowel disease (PSC-IBD) have a very high risk of developing colorectal neoplasia. Alterations in the gut microbiota and/or gut bile acids could account for the increase in this risk. However, no studies have yet investigated the net result of cholestasis and a potentially altered bile acid pool interacting with a dysbiotic gut flora in the inflamed colon of PSC-IBD.
The aim of this study was to compare the gut microbiota and stool bile acid profiles, as well as and their correlation in patients with PSC-IBD and inflammatory bowel disease alone.
Thirty patients with extensive colitis (15 with concomitant primary sclerosing cholangitis) were prospectively recruited and fresh stool samples were collected. The microbiota composition in stool was profiled using bacterial 16S rRNA sequencing. Stool bile acids were assessed by high-performance liquid chromatography tandem mass spectrometry.
The total stool bile acid pool was significantly reduced in PSC-IBD. Although no major differences were observed in the individual bile acid species in stool, their overall combination allowed a good separation between PSC-IBD and inflammatory bowel disease. Compared with inflammatory bowel disease alone, PSC-IBD patients demonstrated a different gut microbiota composition with enrichment in and genus compared with inflammatory bowel disease. At the operational taxonomic unit level major shifts were observed within the (73%) and phyla (17%). Specific microbiota-bile acid correlations were observed in PSC-IBD, where 12% of the operational taxonomic units strongly correlated with stool bile acids, compared with only 0.4% in non-PSC-IBD.
Patients with PSC-IBD had distinct microbiota and microbiota-stool bile acid correlations as compared with inflammatory bowel disease. Whether these changes are associated with, or may predispose to, an increased risk of colorectal neoplasia needs to be further clarified.
原发性硬化性胆管炎合并炎症性肠病(PSC-IBD)患者发生结直肠肿瘤的风险非常高。肠道微生物群和/或肠道胆汁酸的改变可能是导致这种风险增加的原因。然而,尚无研究探讨胆汁淤积以及潜在改变的胆汁酸池与PSC-IBD炎症结肠中失调的肠道菌群相互作用的最终结果。
本研究旨在比较PSC-IBD患者和单纯炎症性肠病患者的肠道微生物群和粪便胆汁酸谱及其相关性。
前瞻性招募30例广泛性结肠炎患者(15例合并原发性硬化性胆管炎),并收集新鲜粪便样本。采用细菌16S rRNA测序分析粪便中的微生物群组成。通过高效液相色谱串联质谱法评估粪便胆汁酸。
PSC-IBD患者的粪便总胆汁酸池显著减少。尽管粪便中各胆汁酸种类未观察到重大差异,但其总体组合可很好地区分PSC-IBD和炎症性肠病。与单纯炎症性肠病相比,PSC-IBD患者的肠道微生物群组成不同,与炎症性肠病相比, 属和 属富集。在操作分类单元水平上,观察到 门(73%)和 门(17%)内有主要变化。在PSC-IBD中观察到特定的微生物群-胆汁酸相关性,其中12%的操作分类单元与粪便胆汁酸强烈相关,而非PSC-IBD中仅为0.4%。
与炎症性肠病相比,PSC-IBD患者具有独特的微生物群以及微生物群与粪便胆汁酸的相关性。这些变化是否与结直肠肿瘤风险增加相关或可能导致其风险增加,有待进一步阐明。